# Use Massive Parallel Sequencing and Exome Capture Technology to Sequence the Exome of Fanconi Anemia Children and Their Patents

> **NCT01995305** · — · AVAILABLE · sponsor: **Xiaofan Zhu**

## Conditions studied

- Fanconi Anemia
- Autosomal or Sex Linked Recessive Genetic Disease
- Bone Marrow Hematopoiesis Failure, Multiple Congenital Abnormalities, and Susceptibility to Neoplastic Diseases.
- Hematopoiesis Maintainance.

## Interventions

- **GENETIC:** human whole exome
- **GENETIC:** whole genomic

## Key facts

- **NCT ID:** NCT01995305
- **Lead sponsor:** Xiaofan Zhu
- **Sponsor class:** UNKNOWN
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01995305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01995305, "Use Massive Parallel Sequencing and Exome Capture Technology to Sequence the Exome of Fanconi Anemia Children and Their Patents". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01995305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*